Enovis - 17 Year Stock Price History | ENOV
Historical daily share price chart and data for Enovis since 2008 adjusted for splits and dividends. The latest closing stock price for Enovis as of March 20, 2025 is 39.35.
- The all-time high Enovis stock closing price was 128.95 on July 01, 2014.
- The Enovis 52-week high stock price is 62.79, which is 59.6% above the current share price.
- The Enovis 52-week low stock price is 35.14, which is 10.7% below the current share price.
- The average Enovis stock price for the last 52 weeks is 46.17.
| Enovis Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 42.8898 | 44.3000 | 47.9900 | 35.5100 | 39.3500 | -10.32% |
| 2024 | 49.9288 | 55.4400 | 63.8000 | 38.7200 | 43.8800 | -21.67% |
| 2023 | 55.7392 | 54.4000 | 65.9200 | 43.6700 | 56.0200 | 4.67% |
| 2022 | 60.2982 | 79.9312 | 80.8434 | 44.8300 | 53.5200 | -32.36% |
| 2021 | 78.5433 | 63.7866 | 91.1704 | 63.7866 | 79.1222 | 20.21% |
| 2020 | 53.1462 | 63.7005 | 66.9535 | 25.1979 | 65.8176 | 5.11% |
| 2019 | 48.9997 | 35.9897 | 62.7539 | 34.7504 | 62.6162 | 74.07% |
| 2018 | 54.7731 | 68.5370 | 71.8761 | 33.0465 | 35.9725 | -47.25% |
| 2017 | 67.9561 | 63.5112 | 74.2857 | 60.0344 | 68.1928 | 10.27% |
| 2016 | 50.2789 | 40.8606 | 68.4165 | 33.2014 | 61.8417 | 53.88% |
| 2015 | 69.9635 | 89.7418 | 92.0310 | 37.8657 | 40.1893 | -54.72% |
| 2014 | 110.5501 | 108.7608 | 128.9501 | 81.2392 | 88.7608 | -19.03% |
| 2013 | 87.6446 | 72.2719 | 109.6213 | 69.6041 | 109.6213 | 57.84% |
| 2012 | 57.0290 | 48.6231 | 69.4492 | 42.6850 | 69.4492 | 41.68% |
| 2011 | 40.1471 | 32.2719 | 54.7332 | 31.2737 | 49.0189 | 54.70% |
| 2010 | 22.9680 | 21.3081 | 32.5301 | 17.6592 | 31.6867 | 52.91% |
| 2009 | 16.6875 | 18.5198 | 23.4596 | 9.3115 | 20.7229 | 15.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.475B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |